Literature DB >> 8565744

Effect of prostaglandin E1 on ammonia concentration in blood of patients with hepatic resection.

T Aono1, T Sakaguchi, K Tsukada, I Kurosaki, K Hatakeyama.   

Abstract

Plasma concentrations of ammonia were examined following prostaglandin E1 (PGE1) administration in 16 patients who received hepatectomy for hepatocellular carcinoma. PGE1 at 0.01-0.04 microgram/kg/min was administered for approximately 24 hr during the perioperative periods. The ammonia concentration was reduced a day after the operation following intravenous administration of PGE1 in cirrhotic patients compared to noncirrhotic patients with or without PGE1 injection. Serum liver function scores, glutamic pyruvic transaminase, and total bilirubin concentrations were decreased after PGE1 administration. A similar ammonia response due to PGE1 was obtained after operation in cirrhotic patient when PGE1 0.5 microgram/kg was administered intravenously for 30 min. These results suggest that PGE1 administration is useful in reducing the enhanced ammonia concentration associated with hepatic resection, and it is particularly effective in the case of liver cirrhosis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8565744     DOI: 10.1007/bf02208593

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  23 in total

1.  Noticeable hyperbilirubinemia following major hepatectomy in patients with biliary tract carcinoma.

Authors:  T Aono; K Tsukada; T Sakaguchi; S Koyama; T Suzuki; K Hatakeyama
Journal:  Nihon Geka Hokan       Date:  1995-03-01

2.  Reduction of the increased portal vascular resistance of the isolated perfused cirrhotic rat liver by vasodilators.

Authors:  P S Bhathal; H J Grossman
Journal:  J Hepatol       Date:  1985       Impact factor: 25.083

3.  Prostaglandin E1 enhances hepatic portal venous flow by dilating the portal vascular bed in 70% hepatectomized dog.

Authors:  K Tsukada; H Katoh; Y Iga; T Tomiyama; N Okamura; F Sugimoto; T Ohtani; T Iiai; T Sakaguchi; K Yoshida
Journal:  Gastroenterol Jpn       Date:  1992-06

4.  Ammonia-induced brain edema and intracranial hypertension in rats after portacaval anastomosis.

Authors:  A T Blei; S Olafsson; G Therrien; R F Butterworth
Journal:  Hepatology       Date:  1994-06       Impact factor: 17.425

5.  Ammonia and related amino acids in the pathogenesis of brain edema in acute ischemic liver failure in rats.

Authors:  M Swain; R F Butterworth; A T Blei
Journal:  Hepatology       Date:  1992-03       Impact factor: 17.425

6.  The effect of pre-operative glucose loading on postoperative nitrogen metabolism.

Authors:  P J Crowe; A Dennison; G T Royle
Journal:  Br J Surg       Date:  1984-08       Impact factor: 6.939

7.  Hepatic and gastric cytoprotective effects of long-term prostaglandin E1 administration in cirrhotic rats.

Authors:  P L Beck; G W McKnight; J K Kelly; J L Wallace; S S Lee
Journal:  Gastroenterology       Date:  1993-11       Impact factor: 22.682

8.  Major hepatic resection for neoplasia: personal experience in 108 patients.

Authors:  J G Fortner; D K Kim; B J Maclean; M K Barrett; S Iwatsuki; A D Turnbull; W S Howland; E J Beattie
Journal:  Ann Surg       Date:  1978-09       Impact factor: 12.969

9.  Limited hepatic resection effective for selected cirrhotic patients with primary liver cancer.

Authors:  T Kanematsu; K Takenaka; T Matsumata; T Furuta; K Sugimachi; K Inokuchi
Journal:  Ann Surg       Date:  1984-01       Impact factor: 12.969

10.  The effect of different calorific doses of carbohydrate on nitrogen excretion after surgery.

Authors:  A Radcliffe; A Johnson; H A Dudley
Journal:  Br J Surg       Date:  1980-07       Impact factor: 6.939

View more
  1 in total

1.  Effect of short-term administration of prostaglandin E1 on viability after ischemia/reperfusion injury with extended hepatectomy in cirrhotic rat liver.

Authors:  Mohammad Akram Hossain; Kunihiko Izuishi; Hajime Maeta
Journal:  World J Surg       Date:  2003-08-21       Impact factor: 3.352

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.